CTLA4 and hepatocellular carcinoma: Also, combination therapies targeting PD-1/PD-L1 and CTLA-4 are very effective in patients with malignant melanoma (42, 43), microsatellite instability high colorectal cancer, and are being investigated in many ongoing clinical trials in patients with HCC (44).